CGEN
Compugen Ltd

2,550
Mkt Cap
$141.24M
Volume
172,693.00
52W High
$2.66
52W Low
$1.13
PE Ratio
-5.05
CGEN Fundamentals
Price
$1.51
Prev Close
$1.61
Open
$1.60
50D MA
$1.69
Beta
1.61
Avg. Volume
284,905.16
EPS (Annual)
-$0.159
P/B
3.22
Rev/Employee
$376,540.54
Loading...
Loading...
News
all
press releases
Compugen (NASDAQ:CGEN) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded Compugen from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·22d ago
News Placeholder
More News
News Placeholder
Analysts Set Expectations for Compugen FY2025 Earnings
Compugen Ltd. (NASDAQ:CGEN - Free Report) - Equities researchers at Leerink Partnrs increased their FY2025 earnings per share estimates for Compugen in a research report issued on Monday, November...
MarketBeat·23d ago
News Placeholder
FY2025 EPS Estimates for Compugen Lifted by Leerink Partnrs
Compugen Ltd. (NASDAQ:CGEN - Free Report) - Investment analysts at Leerink Partnrs raised their FY2025 earnings per share estimates for shares of Compugen in a research note issued on Monday...
MarketBeat·23d ago
News Placeholder
Compugen (NASDAQ:CGEN) Issues Quarterly Earnings Results
Compugen (NASDAQ:CGEN - Get Free Report) released its quarterly earnings results on Monday. The biotechnology company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts...
MarketBeat·26d ago
News Placeholder
Compugen (CGEN) Reports Q3 Loss, Lags Revenue Estimates
Compugen (CGEN) delivered earnings and revenue surprises of +22.22% and -14.43%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·28d ago
News Placeholder
Certara, Inc. (CERT) Q3 Earnings Surpass Estimates
Certara (CERT) delivered earnings and revenue surprises of +27.27% and -0.57%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Compugen to Participate in Stifel 2025 Healthcare Conference
Compugen to Participate in Stifel 2025 Healthcare Conference Compugen to Participate in Stifel 2025 Healthcare Conference PR Newswire HOLON, Israel, Nov. 4, 2025 HOLON, Israel, Nov. 4, 2025...
PR Newswire·1mo ago
News Placeholder
Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Top Estimates
Vertex (VRTX) delivered earnings and revenue surprises of +5.49% and +1.14%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025 Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025 PR Newswire HOLON, Israel, Oct. 27, 2025 HOLON...
PR Newswire·1mo ago
News Placeholder
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025 Compugen to Present Pooled Analysis of COM701 in Three Phase 1...
PR Newswire·2mo ago

Latest CGEN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.